Konstigmin
Konstigmin
Authorised
- Neostigmine bromide
Product identification
Medicine name:
Konstigmin
Active substance:
- Neostigmine bromide
Target species:
-
Horse
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Neostigmine bromide2.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Horse
-
Meat and offal0day
-
Milk0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA03AB93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Vetoquinol GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 6540185.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
